chr11-45805629-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018389.5(SLC35C1):c.-173C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00272 in 1,491,166 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 40 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 33 hom. )
Consequence
SLC35C1
NM_018389.5 5_prime_UTR
NM_018389.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.329
Genes affected
SLC35C1 (HGNC:20197): (solute carrier family 35 member C1) This gene encodes a GDP-fucose transporter that is found in the Golgi apparatus. Mutations in this gene result in congenital disorder of glycosylation type IIc. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 11-45805629-C-T is Benign according to our data. Variant chr11-45805629-C-T is described in ClinVar as [Benign]. Clinvar id is 304734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0137 (2087/152296) while in subpopulation AFR AF= 0.047 (1951/41550). AF 95% confidence interval is 0.0452. There are 40 homozygotes in gnomad4. There are 961 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC35C1 | NM_018389.5 | c.-173C>T | 5_prime_UTR_variant | 1/2 | ENST00000314134.4 | ||
SLC35C1 | XM_011520203.4 | c.-173C>T | 5_prime_UTR_variant | 1/2 | |||
SLC35C1 | NM_001145265.2 | c.-31-181C>T | intron_variant | ||||
SLC35C1 | NM_001145266.1 | c.-31-181C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC35C1 | ENST00000314134.4 | c.-173C>T | 5_prime_UTR_variant | 1/2 | 1 | NM_018389.5 | P4 | ||
SLC35C1 | ENST00000442528.2 | c.-31-181C>T | intron_variant | 1 | A1 | ||||
SLC35C1 | ENST00000526817.2 | c.-31-181C>T | intron_variant | 2 | A1 | ||||
SLC35C1 | ENST00000530471.1 | c.-31-181C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0137 AC: 2084AN: 152178Hom.: 40 Cov.: 32
GnomAD3 genomes
AF:
AC:
2084
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00147 AC: 1965AN: 1338870Hom.: 33 Cov.: 35 AF XY: 0.00128 AC XY: 840AN XY: 654006
GnomAD4 exome
AF:
AC:
1965
AN:
1338870
Hom.:
Cov.:
35
AF XY:
AC XY:
840
AN XY:
654006
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0137 AC: 2087AN: 152296Hom.: 40 Cov.: 32 AF XY: 0.0129 AC XY: 961AN XY: 74466
GnomAD4 genome
AF:
AC:
2087
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
961
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Leukocyte adhesion deficiency type II Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at